KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Biomarin Pharmaceutical (BMRN) over the last 12 years, with Q3 2025 value amounting to $739000.0.

  • Biomarin Pharmaceutical's Exchange Rate Effect rose 12547.4% to $739000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year increase of 643.45%. This contributed to the annual value of $4.8 million for FY2024, which is 26926.61% up from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Exchange Rate Effect stood at $739000.0 for Q3 2025, which was up 12547.4% from -$3.1 million recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Exchange Rate Effect ranged from a high of $3.3 million in Q2 2024 and a low of -$3.6 million during Q4 2023
  • For the 5-year period, Biomarin Pharmaceutical's Exchange Rate Effect averaged around $124894.7, with its median value being $71000.0 (2022).
  • Within the past 5 years, the most significant YoY rise in Biomarin Pharmaceutical's Exchange Rate Effect was 81480.52% (2023), while the steepest drop was 523661.97% (2023).
  • Biomarin Pharmaceutical's Exchange Rate Effect (Quarter) stood at -$22000.0 in 2021, then soared by 422.73% to $71000.0 in 2022, then crashed by 5236.62% to -$3.6 million in 2023, then skyrocketed by 168.66% to $2.5 million in 2024, then plummeted by 70.49% to $739000.0 in 2025.
  • Its Exchange Rate Effect stands at $739000.0 for Q3 2025, versus -$3.1 million for Q2 2025 and -$1.4 million for Q1 2025.